By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sorrento Therapeutics, Inc. 

6042 Cornerstone Court W,

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a



Company News
Sorrento (SRNE) Subsidiary, Scilex, Announces Key Endpoints Met In The European Union Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 1/9/2017 8:25:06 AM
Sorrento (SRNE) Subsidiary, Scilex Announces Key Endpoints Met In Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 12/5/2016 6:55:43 AM
Sorrento (SRNE)'s TNK Therapeutics Provides Progress Update For Its Anti-CD38 And CD123 CAR-T Programs For Treatment Of Hematological Malignancies 12/1/2016 11:47:31 AM
Sorrento (SRNE) Secures $75 Million Loan Facility 11/29/2016 9:43:10 AM
Sorrento (SRNE)'s TNK Therapeutics Subsidiary To Acquire Virttu Biologics 11/17/2016 7:14:34 AM
Sorrento (SRNE) Closes Acquisition Of Scilex 11/9/2016 1:26:03 PM
ARK Animal Health, A Subsidiary Of Sorrento (SRNE), Announces Submission Of Two Major Technical Sections Of A New Animal Drug Application 9/27/2016 10:08:34 AM
Sorrento (SRNE) Appoints Miranda Toledano As Executive Vice President Of Corporate Development, And President Of LA Cell 9/13/2016 6:53:54 AM
Sorrento (SRNE) To Present At Two Upcoming Conferences In New York City 8/31/2016 10:50:44 AM
Sorrento (SRNE)'s Subsidiary Scintilla Pharma Snapped Up Semnur for $200 Million 8/16/2016 6:59:22 AM